David Sussman, Vanessa K Tassone, Fatemeh Gholamali Nezhad, Michelle Wu, Fathima Adamsahib, Gabriella F Mattina, Janneth Pazmino-Canizares, Ilya Demchenko, Hyejung Jung, Wendy Lou, Karim S Ladha, Venkat Bhat
BACKGROUND: With nearly one-third of patients with major depressive disorder being resistant to available antidepressants, there is a need to develop new treatments for this population. Stellate ganglion block (SGB) is a procedure used to block sympathetic input to the central autonomic system; it has been administered to treat several conditions, including pain. Recently, indications for SGB have extended and the potential benefits for psychiatric disorders are under investigation. METHODS: The Local Injection For Treating Mood Disorders (LIFT-MOOD) study investigated the feasibility of a trial of 2 right-sided injections of bupivacaine 0...
2023: Chronic Stress